A simple compound is showing promise in limiting disease progression in multiple sclerosis (MS), reducing relapse rates and new disease activity significantly in mice. According to new research from Dr. Jacqueline Quandt (pictured), published recently in Brain, Behaviour and Immunity, the compound alters immune responses without eliminating cells and in doing so protects the cells in the nervous system and prevents the…
Read More

Canadian Health Research in the Trump Era

Given the difficulties associated with Canadian Institute for Health Research (CIHR) grant applications in the past year, scientists in the Vancouver area and across Canada may be looking to the United States for funding now more than ever. Per a report on Canadian health research conducted in the 2009-2010 fiscal year, over 13% of funding came from foreign sources, the…
Read More
Undergraduate students in Dr. Wyeth Wasserman’s cancer genetics class had a unique assignment: to write their own e-textbook for their course. “Textbooks cost too much and students should have high quality, free materials,” says Dr. Wasserman, who led the project. He is executive director of BC Children’s Hospital Research Institute, professor in the Department of Medical Genetics at the University…
Read More

Scientist in the Spotlight: Benjamin Martin

Ben Martin is a PhD candidate in The Department of Biochemistry and Molecular Biology at the University of British Columbia. In addition to his time spent working under the supervision of Dr. LeAnn Howe, Ben also spent the majority of his graduate studies training as part of the Canadian men’s field hockey team. This has included his participation in the…
Read More
A vote in Canada’s Parliament to approve a genetic privacy bill is creating a self-inflicted political headache for Prime Minister Justin Trudeau’s Liberal government—and could result in a relatively rare and unusual court case. The Genetic Non-Discrimination Act, originally introduced in 2013 by now-retired Liberal Senator James Cowan, is aimed at preventing the use of information generated by genetic tests…
Read More
After spending nearly 15 years in biomedical science laboratories in two different countries with publicly funded health systems, I finally feel able to write down some thoughts on the explosion of physician scientists being trained across the world. I think we have been on a very dangerous path for some time now and need some bold moves at the level…
Read More
Stem cell science belongs to Canada and it is powering regenerative medicine. Today, leaders from across this emerging sector have joined forces to advance the field, through the newly created Regenerative Medicine Alliance of Canada (RMAC). The global market for regenerative medicine is expected to exceed US$49 billion by 2021. Canada is well positioned to compete by moving its innovative…
Read More
ABSTRACT: Nonsense mutations underlie about 10% of rare genetic disease cases. They introduce a premature termination codon (PTC) and prevent the formation of full-length protein. Pharmaceutical gentamicin, a mixture of several related aminoglycosides, is a frequently used antibiotic in humans that can induce PTC readthrough and suppress nonsense mutations at high concentrations. However, testing of gentamicin in clinical trials has shown…
Read More
This week’s #BCTECH Summit commenced with several noteworthy announcements for the BC tech sector. The government has moved a long way towards the things we believe will be important to growing our sector, ensuring a strong pipeline of talent and bolstering the provincial economy.  Many of the announcements in the government’s update to the #BCTECH Strategy are aligned with recommendations…
Read More
"CRISPR-Cas